Clinical Decision Support for Atrial Fibrillation and Flutter

March 5, 2024 updated by: Kaiser Permanente

Reducing Variation in Hospitalization and Processes of Care in Emergency Department Patients With Atrial Fibrillation: A Stepped Wedge Cluster Randomized Trial

Atrial fibrillation (AF) is a major public health problem: it impairs quality of life and independently heightens the risks of ischemic stroke, heart failure and all-cause mortality. AF is a common reason for presenting to emergency departments (ED) in Kaiser Permanente Northern California (KPNC) and is associated with frequent hospitalization. Additionally, inter-facility hospitalization rates for AF vary across KPNC. Improvements in modifiable components of ED AF care could potentially reduce low-yield hospitalizations and the associated costs, patient inconveniences, and complications that can ensue. Real-time clinical decision support systems (CDSS) can transform entrenched physician practices and improve patient outcomes. The investigators will conduct a stepped-wedge cluster randomized trial of a CDSS intervention across 13 KPNC EDs for the comprehensive management of acute AF with the following three aims: 1) To evaluate the impact of the CDSS intervention on index hospitalization rates; 2) To evaluate the impact of the CDSS intervention on ED AF rate and rhythm control process-of-care metrics; and 3) To evaluate the impact of the CDSS intervention on AF stroke prevention actions for eligible participants at the time of ED discharge. The investigators hypothesize that the CDSS intervention will safely reduce index hospitalization rates, improve rate and rhythm control process-of-care metrics, and increase stroke prevention actions for eligible participants at ED discharge and within 30 days.

Study Overview

Status

Active, not recruiting

Study Type

Observational

Enrollment (Estimated)

4000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Antioch, California, United States, 94531
        • Kaiser Permanente Antioch Emergency Department
      • Fremont, California, United States, 94538
        • Kaiser Permanente Fremont Emergency Department
      • Manteca, California, United States, 95337
        • Kaiser Permanente Manteca Medical Center
      • Modesto, California, United States, 95356
        • Kaiser Permanente Modesto Medical Center
      • Oakland, California, United States, 94611
        • Kaiser Permanente Oakland Emergency Department
      • Richmond, California, United States, 94801
        • Kaiser Permanente Richmond Emergency Department
      • Roseville, California, United States, 95661
        • Kaiser Permanente Roseville Emergency Department
      • Sacramento, California, United States, 95823
        • Kaiser Permanente South Sacramento Emergency Department
      • Sacramento, California, United States, 95825
        • Kaiser Permanente Sacramento Emergency Department
      • San Francisco, California, United States, 94115
        • Kaiser Permanente San Francisco Emergency Department
      • San Jose, California, United States, 95119
        • Kaiser Permanente San Jose Emergency Department
      • San Leandro, California, United States, 94577
        • Kaiser Permanente San Leandro Emergency Department
      • San Rafael, California, United States, 94903
        • Kaiser Permanente San Rafael Emergency Department
      • Santa Clara, California, United States, 95051
        • Kaiser Permanente Santa Clara Emergency Department
      • South San Francisco, California, United States, 94080
        • Kaiser Permanente South San Francisco Emergency Department
      • Walnut Creek, California, United States, 94596
        • Kaiser Permanente Walnut Creek Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Adult patients presenting to KPNC emergency departments with eligibility criteria

Description

Inclusion Criteria:

  • Adult (≥18y) KPNC members presenting to the ED with a primary ED diagnosis of atrial fibrillation/flutter (AF/FL). Subjects who meet criteria will be identified electronically within the CDSS tool in the electronic health record.

Exclusion Criteria:

  • Children (<18y).
  • Non-members of KPNC.
  • Patients who were prisoners, pregnant, receiving hospice or palliative care, or who left against medical advice at the index encounter for AF/FL.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Number of patients who were hospitalized
Time Frame: Through emergency department visit, an average of 8 hours
Through emergency department visit, an average of 8 hours
Number of patients who received sustained rate-reduction medications
Time Frame: Through emergency department visit, an average of 8 hours
Through emergency department visit, an average of 8 hours
Number of patients who received stroke prevention interventions
Time Frame: Through emergency department visit, an average of 8 hours
Through emergency department visit, an average of 8 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2021

Primary Completion (Actual)

April 30, 2023

Study Completion (Estimated)

June 30, 2024

Study Registration Dates

First Submitted

August 10, 2021

First Submitted That Met QC Criteria

August 16, 2021

First Posted (Actual)

August 17, 2021

Study Record Updates

Last Update Posted (Estimated)

March 6, 2024

Last Update Submitted That Met QC Criteria

March 5, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe